Cargando…
Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
Disseminated triple negative breast cancer (TNBC) is an incurable disease with limited therapeutic options beyond chemotherapy. Therefore, identification of druggable vulnerabilities is an important aim. Protein kinases play a central role in cancer and particularly in TNBC. They are involved in man...
Autores principales: | Cuenca-López, María Dolores, Serrano-Heras, Gemma, Montero, Juan Carlos, Corrales-Sánchez, Verónica, Gomez-Juarez, Mónica, Gascón-Escribano, Maria José, Carlos Morales, Jorge, Voisin, Veronique, Núñez, Luz Elena, Morís, Francisco, Bader, Gary D., Pandiella, Atanasio, Ocaña, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695035/ https://www.ncbi.nlm.nih.gov/pubmed/26314846 |
Ejemplares similares
-
Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2
por: Pandiella, Atanasio, et al.
Publicado: (2015) -
Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors
por: Serrano-Heras, Gemma, et al.
Publicado: (2015) -
The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia
por: Lopez-Millan, Belen, et al.
Publicado: (2022) -
Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling
por: Montero, Juan Carlos, et al.
Publicado: (2015) -
Erratum: Achilles' heel of triple negative cancer
por: Ocaña, Alberto, et al.
Publicado: (2014)